Fearing Obamacare will drastically increase the cost of health insurance policies next year, some employers are turning to new strategies to blunt or at least delay the "rate shock."
Fearing Obamacare will drastically increase the cost of health insurance policies next year, some employers are turning to new strategies to blunt or at least delay the "rate shock."
Insurers are encouraging small businesses to consider renewing their existing plans early to give companies an extra year to see how Obamacare will affect insurance markets. And many business owners are intrigued, industry experts say.
Insurers also are selling new plans that allow small businesses to self-insure, which also gives companies room to avoid some Obamacare taxes and regulations.
Those strategies, however, are not for everyone, and they come with their own risks, the experts say.
Read the full story here: http://bit.ly/1dL5OGS
Source: The Morning Call
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More